Axxonis Pharma AG

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Continuous Subcutaneous Lisuride Infusion · Neurology
Lisuride is a dopamine agonist that activates dopamine receptors to improve motor symptoms and reduce involuntary movements in Parkinson's disease.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Axxonis Pharma AG portfolio CI brief
Axxonis Pharma AG pipeline updates RSS

Frequently asked questions about Axxonis Pharma AG

What is Axxonis Pharma AG's pipeline?

Axxonis Pharma AG has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Continuous Subcutaneous Lisuride Infusion.

Sector hub: All tracked pharma companies